TCM
AMRI

Timpani Capital Management’s Albany Molecular Research Inc AMRI Stock Holding History

Timpani Capital Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-101,542
Closed -$1.31M – 101
2013
Q3 		$1.31M Sell
101,542
-37,819
-27% -$465K 0.77% 56
2013
Q2 		$1.65M Buy
+139,361
New +$1.51M 1.05% 42

Other funds holding AMRI

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Timpani Capital Management's AMRI Position: Q4 2013 in Review

Timpani Capital Management sold out of Albany Molecular Research Inc (AMRI) in Q4 2013, closing a stake of 101,542 shares — an estimated $1.31M sold.

Timpani Capital Management first reported a position in AMRI in Q2 2013 and held it in 2 quarters. The position peaked at $1.65M in Q2 2013. 118 funds tracked by Wall St. Rank hold AMRI as of Q4 2013.

  • Timpani Capital Management reported no remaining Albany Molecular Research Inc position as of Q4 2013 after selling out during the quarter.
  • Timpani Capital Management sold 101,542 Albany Molecular Research Inc shares in Q4 2013, an estimated $1.31M.
  • Timpani Capital Management first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 2 quarters.
  • Timpani Capital Management's Albany Molecular Research Inc position peaked at $1.65M in Q2 2013.
  • 118 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2013.

Based on Timpani Capital Management's 13F filing for Q4 2013, filed 4 Feb 2014.